RMAT List (37)

Here is a list of firms/products that have self-reported that they have received FDA regenerative medicine advanced therapy designation or RMAT. I’m assuming for the purposes of this resource page that all self-reports are accurate. Note that the links embedded into the firm names are to relevant press releases. A special thanks to some folks at ARM for helping me keep the list up to date.

It was updated as of November 5, 2019 with 37 total:

  1. Abeona Therapeutics (EB-101 Gene Therapy in Epidermolysis Bullosa)
  2. Abeona Therapeutics (ABO-102 Gene Therapy in MPS IIIA)
  3. AlloVir (Viralym-M for hemorrhagic cystitis)
  4. Asterias/BioTime (AST-OPC1, spinal cord injury)
  5. Athersys (MultiStem)
  6. Audentes (AT132 for the Treatment of X-Linked Myotubular Myopathy)
  7. AxoGen (Avance for nerve injuries)
  8. BlueBird Bio (Lentiglobin in SCID)
  9. Caladrius (CD34+ cell therapy for angina)
  10. Capricor (CAP1002, Duchenne Muscular Dystrophy)
  11. CARsgen (CT053 CAR-T therapy for Multiple Myeloma)
  12. Cellerant Therapeutics, Inc/Fibrocell. (Romyelocel-L to Prevent Infections During Neutropenia)
  13. Enzyvant (DiGeorge syndrome)
  14. ExCellThera (ECT-001 for blood cancers
  15. Fibrocell (FCX-007 Gene Therapy for the Treatment of RDEB)
  16. Fortress Biotech/Cellvation (CEVA101, traumatic brain injury)
  17. Humacyte (Vascular Access for Hemodialysis)
  18. Iovance (Lifileucel for metastatic melanoma)
  19. jCyte (Retinitis Pigmentosa)
  20. Juno/Celgene (JCAR017; CAR-T)
  21. Kiadis Pharma (ATIR101, blood disorders)
  22. Krystal Biotech (Gene therapy KB103 for skin disease)
  23. Magenta (MGTA-456 for Inherited Metabolic Disorders)
  24. Mallinckrodt/Stratatech’s Stratagraft
  25. Mesoblast (Heart Failure, mesenchymal precursor cell therapy)
  26. MiMedx Group (AmnioFix for osteoarthritis)
  27. Mustang Bio/St. Judes (MB-107 lentiviral gene therapy for X-linked Severe Combined Immunodeficiency (XSCID))
  28. NightStar Therapeutics (NSR-REP1 for choroideremia)
  29. Orchard Therapeutics (OTL-103 for the Treatment of Wiskott-Aldrich Syndrome)
  30. Poseida Therapeutics (P-BCMA-101 for multiple myeloma)
  31. Rocket Pharma (RP-L102 for Fanconi Anemia)
  32. SanBio (SB623 for the Treatment of Chronic Neurological Motor Deficits Secondary to Traumatic Brain Injury)
  33. Sangamo Therapeutics (SB-525 for Hemophilia A.)
  34. Talaris (FCR-001 for prevention of renal transplantation rejection)
  35. Vericel (Ixmyelocel-T for cardiovascular disease)
  36. ViroMed (VM202 is a DNA based therapy for ALS)
  37. Voyager Therapeutics (VY-AADC for the Treatment of Parkinson’s Disease)